Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.
SSY GroupHKSE:02005 -0.42%86 FCF Yield % is 4.34 as of Jul. 27, 2026, which is 142% above its 10-year median of 1.79. GuruFocus rates HKSE:02005 with a GF Score™ of 86/100 and a GF Value™ of HK$3.04 (Modestly Undervalued). The stock has 8 warning signs investors should review. Among 1,006 Drug Manufacturers companies, SSY Group ranks better than 70.68% on this metric.
FCF Yield % is calculated as Free Cash Flow divided by Market Capitalization. It is a financial solvency ratio that compares the free cash flow a company is expected to earn against its market value.
Similar to Earnings Yield %, FCF Yield % is financial solvency ratio. A lower ratio suggests a less attractive investment, indicating that investors might not receive substantial returns in proportion to their investment. Conversely, a high free cash flow yield signals that a company generates sufficient cash to comfortably meet its debts, obligations, and dividend payments, making it a promising investment choice.
SSY Group FCF Yield % Related Terms
SSY Group FCF Yield % Historical Data
* Premium members only.
The historical data trend for SSY Group's FCF Yield % can be seen below:
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
For the Drug Manufacturers - Specialty & Generic subindustry, SSY Group's FCF Yield %, along with its competitors' market caps and FCF Yield % data, can be viewed below:
* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.
SSY Group FCF Yield % vs Drug Manufacturers Industry
For the Drug Manufacturers industry and Healthcare sector, SSY Group's FCF Yield % distribution charts can be found below:
* The bar in red indicates where SSY Group's FCF Yield % falls into.
* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD. * For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.
SSY Group (HKSE:02005) has a FCF Yield % of 4.34 as of Jul. 27, 2026. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on SSY Group and its competitors. This is 142% above median its historical median of 1.79. According to the industry distribution chart, SSY Group ranks #295 out of 1006 companies in the Drug Manufacturers industry, placing it in the top 29.3%.
Is SSY Group's FCF Yield % too high?
SSY Group's current FCF Yield % of 4.34 is 142% above median its 10-year median of 1.79. The Drug Manufacturers industry median FCF Yield % is 0.75. SSY Group's value of 4.34 is 482.6% above this industry median. Based on the distribution chart, SSY Group ranks #295 out of 1006 companies in the Drug Manufacturers industry, which is above the industry midpoint. Overall, SSY Group has a GF Score™ of 86/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does SSY Group's FCF Yield % compare to ZTS?
According to the Drug Manufacturers industry distribution chart, SSY Group ranks #295 out of 1006 companies for FCF Yield %. This puts SSY Group in the upper half of its industry. The industry median FCF Yield % is 0.75. SSY Group's value of 4.34 is 482.6% above this benchmark. While the company's 10-year median is 1.79 vs. the industry median of 0.75, SSY Group has consistently been above the industry average. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good FCF Yield % for a Drug Manufacturers company?
The median FCF Yield % among Drug Manufacturers companies is 0.75, based on 1,006 companies in the industry. Companies in the top quartile (top 25%) have a FCF Yield % significantly above this median, while those in the bottom quartile fall well below. However, FCF Yield % should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. SSY Group's current FCF Yield % of 4.34 is 482.6% above the industry median. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high FCF Yield % mean?
A high FCF Yield % can signal that a stock is expensive relative to its fundamentals. FCF Yield is calculated as Free Cash Flow divided by Market Capitalization. View historical data on SSY Group and its competitors. For the Drug Manufacturers industry, the median FCF Yield % is 0.75 — values significantly above this may indicate overvaluation, while values below may suggest a bargain or underlying issues. SSY Group's current FCF Yield % is 4.34, which is 142% above median its own 10-year median of 1.79. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is SSY Group stock overvalued right now?
Based on GuruFocus' analysis, SSY Group (HKSE:02005) is currently considered Modestly Undervalued. The stock's GF Value™ is HK$3.04, compared to a current price of HK$2.39 — trading 21.4% below its estimated fair value. The current FCF Yield % is 4.34, which is 142% above median its 10-year median of 1.79 and 482.6% above the Drug Manufacturers industry median of 0.75. SSY Group's overall GF Score™ is 86/100 with 8 warning signs to review. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is FCF Yield % calculated?
FCF Yield % is calculated from a company's financial statements. For SSY Group (HKSE:02005), the current FCF Yield % is 4.34 as of Jul. 27, 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.
Is SSY Group (HKSE:02005) Overvalued in 2026?
Based on GuruFocus' analysis, SSY Group stock appears to be undervalued.
The current stock price of HK$2.39 is trading 21.4% below its estimated GF Value™ of HK$3.04.
GuruFocus considers SSY Group to be Modestly Undervalued.
Key valuation signals for HKSE:02005:
FCF Yield %: 4.34 (142% above median its 10-year median of 1.79)
GF Value™: HK$3.04 vs. price of HK$2.39 (21.4% below fair value)
Industry Position: 482.6% above the Drug Manufacturers median (#295 of 1006)
No single metric tells the full story. See the HKSE:02005 stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.
SSY Group Ltd is engaged in the research, development, manufacturing, and selling of a wide range of pharmaceutical products, which include finished medicines of mainly intravenous infusion solutions and ampoule injections to hospitals and distributors, bulk pharmaceuticals, and medical materials. The company has two reportable segments, including intravenous infusion solutions and other medical materials. The company derives a vast majority of its revenue principally from the Intravenous infusion solution and others. Revenue generation is driven mostly by its sales of pharmaceutical products. The company derives maximum revenue from PRC.
86GF Score
Get the complete analysis for HKSE:02005
FCF Yield % is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.
Quick Browse
Personalize
Premium Gurus 
Create New Portfolio
HKSE:02005 has been successfully added to your 
